论文信息 - Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer. - 字舞流文

Phase II study of second-line gemcitabine in sensitive or refractory small cell lung cancer.

KyungMann Kim | J. Schiller | Paul E Koch | R. Witte | T. Hoang | G. Shapiro | P. Beatty | A. Jaslowski | J. McGovern | Maria B. Quisumbing